Sector consensus Laboratorios Farmaceuticos Rovi, S.A. OTC Markets
Stocks
LABFF
ES0157261019
Pharmaceuticals
|
Market Closed -
OTC Markets
17:30:03 03/08/2026 +04
|
5-day change | 1st Jan Change | ||
| 67.17 USD | +1.98% |
|
-.--% | +1.98% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 1,318.66 | +18.19% | 29 | ||||||
| 277.91 | +4.64% | 22 | ||||||
| 277.31 | +7.85% | 29 | ||||||
| 373.71 | +8.57% | 19 | ||||||
| 153.34 | +11.65% | 22 | ||||||
| 212.3 | +34.09% | 23 | ||||||
| 388.03 | +2.83% | 29 | ||||||
| 310.17 | +12.2% | 23 | ||||||
| 158.15 | +10.04% | 27 | ||||||
| 28.88 | +4.17% | 26 | ||||||
| 569.19 | +10.43% | 27 | ||||||
| 66.42 | +4.36% | 24 | ||||||
| 94.06 | +28.39% | 24 | ||||||
| 21.61 | +22.08% | 21 | ||||||
| 9,323.33 | +45.18% | 15 | ||||||
| 6,603.31 | +16.54% | 16 | ||||||
| 58.22 | +20.87% | 18 | ||||||
| 41.91 | +12.99% | 11 | ||||||
| 71.35 | +67.22% | 17 | ||||||
| Average | 1,070.94 | +18.02% | 22 | ||||||
| Weighted average by Cap. | 714.81 | +13.63% | 25 |
Select your edition
All financial news and data tailored to specific country editions
